Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis
Intravenous golimumab proves to be efficacious and safe for inducing and sustaining remission in JIA and JIA-associated uveitis. Nonetheless, further robust studies with larger sample sizes are needed to substantiate our findings.
Authors
- Sohum Sheth (ORCID: https://orcid.org/0000-0002-1138-6135)
- Arash Maleki (ORCID: https://orcid.org/0000-0001-5533-9798)
- Khushi Saigal (ORCID: https://orcid.org/0009-0004-8031-3206)
- Shawn Khan (ORCID: https://orcid.org/0009-0004-9850-5978)
Institutions
- University of Florida (US)
- Ocular Immunology and Uveitis Foundation (US)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1080/09273948.2024.2391985
- Citations
- 2
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 1.08